Opendata, web and dolomites

iaFRET

An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "iaFRET" data sheet

The following table provides information about the project.

Coordinator
FASTBASE SOLUTIONS SOCIEDAD LIMITADA 

Organization address
address: C/ AREATZA HIRIBIDEA 47
city: PLENTZIA
postcode: 48620
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.fastbasesolutions.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2018-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FASTBASE SOLUTIONS SOCIEDAD LIMITADA ES (PLENTZIA) coordinator 50˙000.00

Map

 Project objective

Chemotherapy remains the main treatment in locally advanced or metastatic lung cancer. The wide use of chemotherapies is often lengthy (4 months) and is not supported by any patient stratification tools, leading to life-threatening risk. current techniques used to identify biomarkers for target or immunotherapy (i.e. Immunohistochemistry and Protein Ligase Assays) lack of sensitivity (up to 30% of false negatives) resulting in qualitative, subjective measurements with poor prognostic value. iaFRET is an imaging system based on a proprietary time resolved Amplified Forester Resonance Energy Transfer (FRET) technique. It determines both molecular and cell-cell interactions, enabling the evaluation of clinical efficiency of personalised cancer treatments. iaFRET enables oncologists to define the most effective treatment for cancer case and verify its efficacy anytime during the therapy. FASTBASE will need to finalise the engineering of the machine, optimize the image analysis algorithms and user interface, conduct a clinical trial to demonstrate and validate the safety, efficacy and cost savings of technology. Globally there are almost 300 research institutes and hospitals currently working on cancer research worldwide, 147 in EU. Emerging frontiers like immunotherapy highly require technology like iaFRET. iaFRET can contribute to European health system by improving the prognosis and treatment selection for cancer patients, hence increasing the life expectancy of patients affected by this pathology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IAFRET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IAFRET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More